The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Elevated HOXC6/DLX1 mRNA biomarker levels in urine to help select patients at increased risk for high-grade prostate cancer detection upon prostate biopsy.
 
Rianne Hendriks
No Relationships to Disclose
 
Siebren Dijkstra
No Relationships to Disclose
 
Erik Bastiaan Cornel
No Relationships to Disclose
 
Sander Jannink
No Relationships to Disclose
 
Hans de Jong
No Relationships to Disclose
 
Daphne Hessels
Employment - Noviogendix
Leadership - Noviogendix
Stock and Other Ownership Interests - Noviogendix
Honoraria - Noviogendix
 
Willem Melchers
No Relationships to Disclose
 
Frank Smit
No Relationships to Disclose
 
Gisele Leyten
No Relationships to Disclose
 
Theo De Reijke
No Relationships to Disclose
 
Henk Vergunst
No Relationships to Disclose
 
Paul Kil
No Relationships to Disclose
 
Ben Knipscheer
No Relationships to Disclose
 
Christina Hulsbergen-van de Kaa
No Relationships to Disclose
 
Peter Mulders
Honoraria - Astellas Pharma; Bayer; Janssen-Cilag
Consulting or Advisory Role - Astellas Pharma (Inst); Bayer (Inst); Janssen-Cilag (Inst)
Speakers' Bureau - Astellas Pharma; Bayer; Janssen-Cilag
Research Funding - AstraZeneca (Inst); Bayer (Inst)
 
Inge Van Oort
Consulting or Advisory Role - Astellas Pharma (Inst); GlaxoSmithKline (Inst); Janssen-Cilag (Inst); Sanofi (Inst)
Speakers' Bureau - GlaxoSmithKline
 
Jack Schalken
Employment - Noviogendix
Leadership - Noviogendix
Stock and Other Ownership Interests - Noviogendix
Honoraria - Astellas Pharma; Noviogendix
Consulting or Advisory Role - Hologic
Speakers' Bureau - Astellas Pharma; Sanofi
Patents, Royalties, Other Intellectual Property - Noviogendix; Radboudumc
Expert Testimony - Mylan